microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (Review)

Lung cancer remains the leading cause of cancer-related death worldwide for both men and women, and non-small cell lung cancer (NSCLC) accounts for approximately 80% of all cases. Despite improvements in early diagnosis and newly developed therapies, the 5-year survival rate for NSCLC patients remai...

Descripción completa

Detalles Bibliográficos
Autores principales: JIANG, YAN-WEN, CHEN, LIANG-AN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493048/
https://www.ncbi.nlm.nih.gov/pubmed/22307769
http://dx.doi.org/10.3892/mmr.2012.776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493048/
https://www.ncbi.nlm.nih.gov/pubmed/22307769
http://dx.doi.org/10.3892/mmr.2012.776

Ejemplares similares